Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean haydon park (36 results)?
Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting.
Yang H, Park H, Lee YJ, Choi JY, Kim T, Rajasekaran N, Lee S, Song K, Hong S, Choi JS, Shim H, Kim YD, Hwang S, Choi YL, Shin YK. Yang H, et al. Among authors: park h. Biomolecules. 2019 Dec 28;10(1):51. doi: 10.3390/biom10010051. Biomolecules. 2019. PMID: 31905631 Free PMC article.
Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
Yeo SM, Park H, Paek JH, Park WY, Han S, Park SB, Jin K. Yeo SM, et al. Among authors: park h. Medicine (Baltimore). 2019 Jan;98(3):e14150. doi: 10.1097/MD.0000000000014150. Medicine (Baltimore). 2019. PMID: 30653152 Free PMC article.
Ensemble confidence intervals for binomial proportions.
Park H, Leemis LM. Park H, et al. Stat Med. 2019 Aug 15;38(18):3460-3475. doi: 10.1002/sim.8189. Epub 2019 May 17. Stat Med. 2019. PMID: 31099897
Accuracy of three-dimensional cephalograms generated using a biplanar imaging system.
Park HY, Lee JS, Cho JH, Hwang HS, Lee KM. Park HY, et al. Korean J Orthod. 2018 Sep;48(5):292-303. doi: 10.4041/kjod.2018.48.5.292. Epub 2018 Aug 8. Korean J Orthod. 2018. PMID: 30206528 Free PMC article.
A New TGF-β1 Inhibitor, CTI-82, Antagonizes Epithelial-Mesenchymal Transition through Inhibition of Phospho-SMAD2/3 and Phospho-ERK.
Jeong JH, Kim H, Park SH, Park H, Jeong M, Kwak S, Sung GJ, Song JH, Na Y, Choi KC. Jeong JH, et al. Among authors: park h. Biology (Basel). 2020 Jun 28;9(7):E143. doi: 10.3390/biology9070143. Biology (Basel). 2020. PMID: 32605257 Free article.
Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer.
Kim J, Park KE, Jeong YS, Kim Y, Park H, Nam JH, Jung K, Son WS, Jung HS, Lee JH, Jeong SH, Kim NA, Ha JD, Cho SY, Choi YL, Chung SJ, Choi JY, Hong S, Shin YK. Kim J, et al. Among authors: park h. Cancers (Basel). 2020 Jun 15;12(6):1575. doi: 10.3390/cancers12061575. Cancers (Basel). 2020. PMID: 32549194 Free PMC article.
Feedback